Literature DB >> 17412781

Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2alpha.

Alan C Moss1, Pauline Anton, Tor Savidge, Paul Newman, Adam S Cheifetz, Jerome Gay, Sophia Paraschos, Michael Weinstein Winter, Mary P Moyer, Katia Karalis, Efi Kokkotou, Charalabos Pothoulakis.   

Abstract

BACKGROUND/AIMS: Urocortin II (UcnII) is a neuropeptide that binds with high affinity to the corticotropin-releasing hormone receptor 2 (CRHR2) in peripheral tissues. UcnII is synthesised in the intestine, but its role in human intestinal inflammation is largely unknown.
METHODS: Responses of human colonic epithelial cells expressing CRHR2 to stimulation by UcnII were measured using ELISA, western blot analysis, real-time reverse transcription-PCR (RT-PCR) and interleukin (IL)8 promoter activity. Expression levels of CRHR2 and UcnII in human colitis were determined by immunofluorescence and real-time RT-PCR in mucosal biopsies from patients with Crohn's and ulcerative colitis, and in human intestinal xenografts after exposure to Clostridium difficile toxin A.
RESULTS: It is reported here that expression of CRHR2 mRNA and protein in human colonic epithelial cells (HT-29) are increased by exposure to C difficile toxin A or tumour necrosis factor (TNF)alpha. Stimulation of non-transformed NCM460 colonocytes overexpressing CRHR2alpha receptor with UcnII resulted in a time- and concentration-dependent increase in IL8 production. UcnII stimulation also led to activation of nuclear factor-kappaB (NF-kappaB) and mitogen-acivated protein (MAP) kinase in these cells, as evidenced by degradation of IkappaBalpha and phosphorylation of the p65 subunit of NF-kappaB and extracellularly regulated kinase (ERK) 1/2. Furthermore, expression of UcnII and CRHR2 mRNA was increased in mucosal samples of patients with inflammatory bowel disease, and after exposure of human intestinal xenografts to C difficile toxin A.
CONCLUSIONS: These results suggest that UcnII has pro-inflammatory effects in human intestinal cells via the CRHR2alpha receptor and may play an important role in the pathophysiology of colitis in humans.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17412781      PMCID: PMC1954994          DOI: 10.1136/gut.2006.110668

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  49 in total

1.  Regulation of nuclear factor-kappaB by corticotropin-releasing hormone in mouse thymocytes.

Authors:  Jie Zhao; Katia P Karalis
Journal:  Mol Endocrinol       Date:  2002-11

2.  Urocortin 2 suppresses host resistance to Listeria monocytogenes infection via up-regulation of interleukin-10.

Authors:  Hiroshi Sashinami; Kazunori Kageyama; Toshihiro Suda; Akio Nakane
Journal:  Endocrinology       Date:  2005-08-04       Impact factor: 4.736

3.  Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway.

Authors:  Jing Cao; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Mol Pharmacol       Date:  2005-12-06       Impact factor: 4.436

4.  Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells.

Authors:  Dalila Darmoul; Valérie Gratio; Hélène Devaud; Thérèse Lehy; Marc Laburthe
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

5.  Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta.

Authors:  Kazunori Kageyama; Ken-Ichi Furukawa; Izumi Miki; Ken Terui; Shigeru Motomura; Toshihiro Suda
Journal:  J Cardiovasc Pharmacol       Date:  2003-10       Impact factor: 3.105

6.  Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides.

Authors:  Bhawanjit K Brar; Alon Chen; Marilyn H Perrin; Wylie Vale
Journal:  Endocrinology       Date:  2003-12-11       Impact factor: 4.736

7.  Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.

Authors:  Tor C Savidge; Wei-Hua Pan; Paul Newman; Michael O'brien; Pauline M Anton; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2003-08       Impact factor: 22.682

8.  Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes.

Authors:  Iordanes Karagiannides; Efi Kokkotou; Morris Tansky; Tamara Tchkonia; Nino Giorgadze; Michael O'Brien; Susan E Leeman; James L Kirkland; Charalabos Pothoulakis
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-20       Impact factor: 11.205

9.  Role of corticotropin-releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors.

Authors:  Catherine L Rivier; Dimitri E Grigoriadis; Jean E Rivier
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

10.  Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells.

Authors:  Rajinder S Sawhney; Bhavya Sharma; Lisa E Humphrey; Michael G Brattain
Journal:  J Biol Chem       Date:  2003-03-25       Impact factor: 5.157

View more
  35 in total

Review 1.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

Review 2.  Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.

Authors:  M Larauche; C Kiank; Y Tache
Journal:  J Physiol Pharmacol       Date:  2009-12       Impact factor: 3.011

3.  Protective effects of Lactobacillus plantarum against epithelial barrier dysfunction of human colon cell line NCM460.

Authors:  Zhi-Hua Liu; Tong-Yi Shen; Peng Zhang; Yan-Lei Ma; Mary Pat Moyer; Huan-Long Qin
Journal:  World J Gastroenterol       Date:  2010-12-07       Impact factor: 5.742

4.  Corticotropin-releasing factor receptor subtype 2 in human colonic mucosa: down-regulation in ulcerative colitis.

Authors:  Ekaterini Chatzaki; Peter A Anton; Mulugeta Million; Maria Lambropoulou; Theodoros Constantinidis; George Kolios; Yvette Taché; Dimitri E Grigoriadis
Journal:  World J Gastroenterol       Date:  2013-03-07       Impact factor: 5.742

5.  Endogenous CRF in rat large intestine mediates motor and secretory responses to stress.

Authors:  S Liu; J Chang; N Long; K Beckwith; G Talhouarne; J J Brooks; M-H Qu; W Ren; J D Wood; S Cooper; A Bhargava
Journal:  Neurogastroenterol Motil       Date:  2015-11-26       Impact factor: 3.598

6.  Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes.

Authors:  Christina Chandras; Yassemi Koutmani; Efi Kokkotou; Charalabos Pothoulakis; Katia P Karalis
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

Review 7.  Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Authors:  Cornelia Kiank; Yvette Taché; Muriel Larauche
Journal:  Brain Behav Immun       Date:  2009-08-19       Impact factor: 7.217

8.  Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.

Authors:  Rongjian Zhang; Youhua Xu; Hong Fu; Juejin Wang; Lai Jin; Shengnan Li
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

9.  Urocortins and CRF receptor type 2 variants in the male rat colon: gene expression and regulation by endotoxin and anti-inflammatory effect.

Authors:  Pu-Qing Yuan; S Vincent Wu; Charalabos Pothoulakis; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

10.  Corticotropin-Releasing Hormone Receptor 2 Signaling Promotes Mucosal Repair Responses after Colitis.

Authors:  Jill M Hoffman; Stavroula Baritaki; Jonathan J Ruiz; Aristea Sideri; Charalabos Pothoulakis
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.